March 28, 2022 3:15 pm
Published by jonas
Redwood Pharma har erhållit godkännande från den österrikiska läkemedelsmyndigheten (Austrian Federal Office for Safety in Health Care, BASG) att inleda den... View Article
March 25, 2022 10:13 am
Published by jonas
The causes of dry eye disease and degrees of severity in patients vary widely. Today there is no single silver... View Article
March 11, 2022 12:00 pm
Published by jonas
Based on the IntelliGel platform which delivers moisturizing water and protection for the eye, RP501 is Redwood Pharma’s developmental hydrogel... View Article
February 16, 2022 8:30 am
Published by jonas
NASDAQ FIRST NORTH GROWTH MARKET:REDW.ST, REDWOODPHARMA.SE Perioden 1 januari – 31 december 2021 Bolagets nettoomsättning för perioden uppgick till 0... View Article
February 7, 2022 2:24 pm
Published by jonas
Redwood Pharma har erhållit godkännande från den österrikiska etikkommittén att starta en klinisk prövning av RP501. Ansökan utgör det första... View Article
January 24, 2022 1:52 pm
Published by jonas
Redwood Pharma will be attending two of the leading international conferences in ophthalmology and biotechology during 2022. The goals of... View Article
December 16, 2021 11:11 am
Published by jonas
Redwood Pharma extends its reach into the medical technology arena with the broadening of its development programs with the RP501... View Article
November 30, 2021 2:21 pm
Published by jonas
VD Martin Vidaeus uppdaterar den 30 november 2021 aktieägarna och marknaden om bolaget, RP501 och planerna för kommande året. Klicka följande... View Article
November 16, 2021 8:00 am
Published by jonas
NASDAQ FIRST NORTH GROWTH MARKET: REDW.ST, redwoodpharma.se Redwood Pharma AB (publ) Delårsrapport januari–september 2021 Perioden 1 januari – 30 september... View Article
October 25, 2021 8:50 am
Published by jonas
Redwood Pharma offentliggör idag en strategisk förändring i form av accelererad utveckling av RP501, bolagets IntelliGel-baserade topikala terapi för torra... View Article